Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
15.5%
% of VHT's 415 holdings also in IXJ
53.6%
% of IXJ's 113 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 9.6% | 9.6% |
|
UNITEDHEALTH GROUP INC | 7.4% | 6.0% | 6.0% |
|
JOHNSON & JOHNSON | 5.0% | 5.5% | 5.0% |
|
ABBVIE INC | 4.9% | 4.4% | 4.4% |
|
ABBOTT LABORATORIES | 4.0% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to IXJ
|
ELI LILLY & CO | 2.4% |
|
UNITEDHEALTH GROUP INC | 1.4% |
|
ABBOTT LABORATORIES | 0.7% |
|
VEEVA SYSTEMS INC-CLASS A | 0.6% |
|
INTUITIVE SURGICAL INC | 0.6% |
|
ALNYLAM PHARMACEUTICALS INC | 0.5% |
|
THERMO FISHER SCIENTIFIC INC | 0.5% |
|
AMGEN INC | 0.5% |
|
MERCK & CO. INC. | 0.5% |
|
BOSTON SCIENTIFIC CORP | 0.5% |
VHT Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -3.2% |
|
NOVARTIS AG | -3.2% |
 |
ASTRAZENECA PLC | -3.0% |
 |
NOVO NORDISK A/S-B | -2.9% |
 |
SANOFI-AVENTIS | -1.6% |
|
ESSILOR INTERNATIONAL | -1.2% |
 |
CSL LIMITED | -1.1% |
|
GSK PLC | -1.1% |
|
LONZA GROUP AG-REG | -0.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |